Foam sclerotherapy: Cardiac and cerebral monitoring

Phlebology

Volumn 24, Issue 6, 2009, Pages 252-259

  Morrison, N ^a   Neuhardt, D L ^b  

^a Morrison Vein Institute   (United States)

^b Clinical Ultrasound Specialists ^*  (United States)

Author keywords

Cerebral emboli; Foam sclerotherapy

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; POLIDOCANOL;

ARTICLE; BRAIN EMBOLISM; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; ECHOENCEPHALOGRAPHY; FOAM; GAS EMBOLISM; HUMAN; INJECTION SITE; LEG VARICOSIS; PATIENT MONITORING; PRIORITY JOURNAL; SAPHENOUS VEIN; SCLEROTHERAPY; TRANSTHORACIC ECHOCARDIOGRAPHY;

DOSAGE FORMS; ECHOCARDIOGRAPHY; ELECTROCOAGULATION; EMBOLISM, AIR; HEART DISEASES; HUMANS; INTRACRANIAL EMBOLISM; MIDDLE CEREBRAL ARTERY; MONITORING, PHYSIOLOGIC; SAPHENOUS VEIN; SCLEROSING SOLUTIONS; SCLEROTHERAPY; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS;

EID: 72149103525     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.009051     Document Type: Article

References (61)

1. Breu FX, Guggenbicher S, Wollman JC. Second European Consensus Meeting on Foam Sclerotherapy. Duplex Ultrasound and Efficacy Criteria in Foam Sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy, 2006, Tegernsee, Germany. VASA 2008;37:90-95
2. Morrison N, Neuhardt DL, Rogers CR, et al. Comparison of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-836
3. Benigni JP, Sadoun S, Thirion V, et al. Telangiectasias et varices reticulaires: Traitment par la mousse d'Aetoxisclerol a 0.25 Presentation d'une etude pilote. Phlebologie 1999;3:283-288
4. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002;28:11-15 (Pubitemid 34101573)
5. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-18 (Pubitemid 35231053)
6. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-121 (Pubitemid 44872674)
7. Tessari L, Cavezzi A, Frulini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60 (Pubitemid 32107620)
8. Wright D, Gobin JP, Bradbury AW, et al. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-190 (Pubitemid 44913249)
9. Bergan JJ, Pascarella L. Severe chronic venous insufficiency: primary treatment with sclerofoam. Semin Vasc Surg 2005;18:49-56 (Pubitemid 40386979)
10. Cabrera J, Redondo P, Becerra A, et al. Ultrasound guided injection of polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol 2004;140:667-673 (Pubitemid 38747281)
11. de Waard MM, der Kinderen DJ. Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator viens in a patient with bilateral venous leg ulcers. Dermatol Surg 2005;31:580-583
12. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosants in microfoam form. Arch Dermatol 2003;139:1409-1416 (Pubitemid 37433130)
13. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long term outcomes. Phlebology 2000;15:19-23 (Pubitemid 30739995)
14. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardized polidocanol foam (ESAF): a randomized controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008;35:238-245 (Pubitemid 351163086)
15. Cavezzi A, Frullini A. The role of sclerosant foam in ultrasound guided sclerotherapy of the saphenous veins and of recurrent varicose veins. Aust NZ J Phlebol 1999;3:49-50
16. Masuda EM, Kessler DM, Lurie F, Puggioni A, Kistner RL, Eklof B. The effect of ultrasound-guided sclerotherapy of incompetent perforator veins on venous clinical severity and disability scores. J Vasc Surg 2006;43:551-567 (Pubitemid 43332741)
17. Nitecki S, Bass A. Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome. Isr Med Assoc J 2007;9:72-75 (Pubitemid 46351244)
18. Pascarella L, Bergan JJ, Yamada C, Mekenas L. Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg 2005;19:457-464 (Pubitemid 41126041)
19. Ricci S, Georgiev M, Jawien A, Zamboni P. Sciatic nerve varices. Eur J Vasc Endovasc Surg 2005;29:83-87
20. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-722 (Pubitemid 38657962)
21. Smith PC. Foam and liquid sclerotherapy for varicose veins. Phlebology 2009;24(Suppl. 1):62-72
22. Morrison N. Foam sclerotherapy: how to improve results and reduce side effects? Phlebology 2008;34:211-220
23. Neuhardt DL, Salles-Cunha SX, Morrison N. Emboli detection in the middle cerebral artery during and following foam sclerotherapy (room air) of lower extremity veins. Phlebology 2008;23(Suppl. 1):8
24. Alós J, Carreño P, López JA, Estadella B, Serra-Prat M, Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-107 (Pubitemid 43024991)
25. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001;20:322-329
26. Ceulen RP, Bullens-Goessens YI, Pi-Van de Venne SJ, Nelemans PJ, Veraart JC, Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with one-year follow-up. Dermatol Surg 2007;33:276-281 (Pubitemid 46328226)
27. Hamel-Desnos C, Owvry P, Bdenigni J-P, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomized, double-blind trial with two year-follow-up. 'The 3/1 study'. Eur J Vasc Endovasc Surg 2007;34:723-729
28. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomized controlled trial with a two-year follow-up. Eur J Vasc Endovasc Surg 2008;36:366-370
29. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005;31:631-635 (Pubitemid 43093412)
30. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008;47:578-584 (Pubitemid 351258277)
31. Breu FX, Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. VASA 2008;37-S71:3-29
32. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovas Surg 2006;32:577-583
33. Morrison N, Cavezzi A, Bergan J, Partsch H. Letter to the editor regarding 'Stroke after varicose vein foam injection sclerotherapy'. J Vasc Surg 2007;44:224-225
34. Bush RG, Derrick M, Manjonev D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-192
35. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-164 (Pubitemid 43083525)
36. Gillet J-L, Guedes JM, Guex J-J, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24:131-138
37. Hansen K, Morrison N, Neuhardt DL, Salles-Cunha SX. Transthoracic echocardiogram and transcranial doppler detection of emboli after foam sclerotherapy of leg veins. J Vasc Ultrasound 2007;31:213-216
38. Morrison N, Neuhardt DL, Rogers C, McEown J, Vollis K. Studies on foam migration. Phlebology 2009;24:88
39. Morrison N. Studies on safety of foam sclerotherapy. In: Bergan J, Cheng V, eds. Foam Sclerotherapy: A Textbook. London: Royal Society of Medicine Press, 2008:183-192
40. Morrison N, Neuhardt DL, Hansen K, Levin S, Salles-Cunha SX. Tracking foam to the heart and brain following ultrasound-guided sclerotherapy of lower extremity veins. Austral NZ J Phlebol 2007;10:6-9
41. Neuhardt DL, Morrison N, Rogers C, Salles-Cunha SX. Emboli detection in the middle cerebral artery concurrent with treatment of lower extremity superficial venous insufficiency with foam sclerotherapy (CO2O2). Phlebology 2009;24:88-89
42. Morrison N. VNUS closure of the saphenous vein. In: Bergan JJ, ed. The Vein Book. Burlington, MA: Elsevier Academic Press, 2007
43. Hill D, Hamilton R, Fung T. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vasc Surg 2008;48:934-939
44. Tessari L. Nouvelle technique d'obtention de la scleromousse. Phlebologie 2000;53:129-133
45. Ceulen RPM, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-1526 (see reference for comment and authors' reply)
46. Guex J-J, Raymond-Martimbeau P, Simka M, Passariello F. Letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England Journal of Medicine. Phlebology 2008;23:249
47. Ceulen RPM, Vernooy K. Reply to letter regarding article titled 'Microembolism during foam sclerotherapy of varicose veins' in the New England Journal of Medicine. Phlebology 2008;23:250
48. Rush JE, Wright DDI. More on microembolism and foam sclerotherapy. N Engl J Med 2008;359:656-657 (comment on reference, authors' reply, p. 657)
49. Neuhardt DL, Morrison N, Salles-Cunha S. Cerebral emboli comparison detected by transcranial Doppler during ultrasound guided sclerotherapy using C0202 based foam or air-based foam. Abstract Presentation UIP 16th World Congress, 2009, Monte Carlo, Monaco
50. Regan JD, Gibson KD, Ferris B, et al. Safety of proprietary sclerosant microfoam for saphenous incompetence in patients with R-to L shunt: interim report. J Vasc Interv Radiol 2008;19(Suppl.):S35
51. Raymond-Martimbeau P. Detection of patent foramen ovale before foam sclerotherapy. Phlebology 2008;23(Suppl. 1):7
52. Raymond-Martimbeau P. Transient adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy. Phlebology 2009;24:88, 114-119
53. Wright DDI, McCollum CN, Tristram S, Rush JE. A single-centre pilot study of polidocanol endovenous microfoam treatment to evaluate the presence and durability of gas emboli using echocardiography. Phlebology 2009;24:85-95
54. Abad C, Antunez M, Cabrero A. Pulmonary thromboembolism after sclerotherapy of a varicose vein in the lower limb. An Med Interna 2004;21:415-416 (Pubitemid 39369591)
55. Harzheim M, Becher H, Klockgether T. Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr 2000;125:794-796
56. Marrocco-Trischitta MM, Guerrini P, Abeni P, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 2002;28:153-155 (Pubitemid 34177355)
57. Sylvoz N, Villier C, Blaise S, Seinturier C, Mallaret M. Polidocanol induced cardiotoxicity: a case report and review of the literature. J Mal Vasc 2008;33:234-238 (Pubitemid 351555878)
58. Trenkwalder P, Lydtin H. Ischaemic neurological deficit after sclerotherapy. Lancet 1994;343:794
59. Hagan PT, Schulz DG, Edwards WD. Incidence and size of patent foramen ovale during the first ten decades of life: an autopsy study of 965 normal hearts. Mayo Clinic Proc 1984;59:17-20
60. Passarielo F. The point on: an international on line debate foam sclerotherapy and patent foramen ovale. Acta Phlebol 2008;9:47-54
61. Eckman DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg 2005;31:636-643 (Pubitemid 43093414)